BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/17/2022 4:40:53 AM | Browse: 491 | Download: 1070
 |
Received |
|
2022-06-15 19:34 |
 |
Peer-Review Started |
|
2022-06-15 19:37 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2022-08-01 09:31 |
 |
Revised |
|
2022-08-10 16:58 |
 |
Second Decision |
|
2022-10-19 03:50 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2022-10-19 17:37 |
 |
Articles in Press |
|
2022-10-19 17:37 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2022-11-07 16:59 |
 |
Typeset the Manuscript |
|
2022-11-13 23:56 |
 |
Publish the Manuscript Online |
|
2022-11-17 04:40 |
ISSN |
2220-3230 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Review |
Article Title |
Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation
|
Manuscript Source |
Invited Manuscript |
All Author List |
Konstantinos Ouranos, Anthi Chatziioannou, Ioannis Goulis and Emmanouil Sinakos |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Konstantinos Ouranos, MD, N/A, N/A, 4th Medical Department, Hippokratio Hospital, Aristotle University of Thessaloniki, 49, Konstantinoupoleos Str, Thessaloniki 54642, Greece. kostassky@hotmail.com |
Key Words |
Hepatocellular carcinoma; Immunotherapy; Tumor downsizing; Liver transplantation; Neoadjuvant; Rejection |
Core Tip |
Immunotherapy has been used in the treatment of advanced hepatocellular carcinoma (HCC) with promising results. Extending its use in the preoperative period prior to liver transplantation (LT), either alone or in combination with other locoregional treatment modalities, could increase the pool of potential LT candidates. Data from case reports and ongoing clinical trials assessing neoadjuvant immunotherapy prior to LT could revolutionize the current consensus regarding HCC downsizing practices and improve survival of patients with this type of malignancy. |
Publish Date |
2022-11-17 04:40 |
Citation |
Ouranos K, Chatziioannou A, Goulis I, Sinakos E. Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation. World J Transplant 2022; 12(11): 331-346 |
URL |
https://www.wjgnet.com/2220-3230/full/v12/i11/331.htm |
DOI |
https://dx.doi.org/10.5500/wjt.v12.i11.331 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345